FDA Drugs (New Approvals & NDA)Original article
Inter-governmental Working Meeting on Drug Compounding, October 10-11, 2019
RegulatoryNeutral
AI Analysis
Summary
FDA and state regulators held an inter-governmental working meeting on October 10-11, 2019 to strengthen oversight of drug compounders through improved federal-state collaboration and public health protection.
Importance:2/10
Sentiment:
0.00
regulatorycompoundingFDAstate-collaborationpublic-health
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on June 3, 2026 8:24 PM